<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260929071238N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-05</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effect of family empowerment on self-management in adolescents with type 1 diabetes</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of a Family-Centered Empowerment Model on Self-Management in Adolescents with Type 1 Diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/93782</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: The study is a randomized controlled trial (RCT), parallel-group, open-label design. Participants are allocated to either the intervention or control group using block randomization (block size of 4). Allocation concealment is ensured using Sequentially Numbered, Opaque, Sealed Envelopes (SNOSE), Randomization description: Eligible adolescents, following screening based on inclusion and exclusion criteria, were allocated into intervention (family-centered empowerment model) and control groups in a 1:1 ratio using permuted block randomization with a block size of 4. The random allocation sequence was generated using a table of random numbers. To ensure allocation concealment, sequentially numbered, opaque, sealed envelopes (SNOSE) were utilized; each participant’s envelope was opened sequentially only after obtaining written informed consent and confirming enrollment by an individual independent of the intervention team.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Type 1 Diabetes Mellitus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in the intervention group along with one of their parents will participate in an educational program based on the Family-Centered Empowerment Model (FCEM). The program consists of six 90-minute educational sessions conducted bi-weekly over 3 months (in-person and in small groups) at the hospital diabetes clinic. The intervention follows four steps: 1) Enhancing perceived threat (knowledge about diabetes nature, complications, and consequences of poor control), 2) Improving self-efficacy through problem-solving and practical skills (hands-on blood glucose monitoring, insulin injection technique, dietary and physical activity management, and handling emergencies), 3) Increasing self-esteem through educational participation (reinforcing the adolescent’s role as an educational ambassador to share learning with family members and peer discussions), and 4) Formative and summative evaluation (assessing knowledge retention, addressing questions, and treatment adherence). An educational booklet will also be provided at the end of the intervention. Intervention 2: Control group: Participants in the control group will only receive routine care and standard education provided at the hospital diabetes clinic (including periodic physician visits and standard advice from healthcare providers), with no structured empowerment program. To comply with research ethics, an educational summary booklet of the empowerment model will be provided to the control group participants and their families after completion of the study and post-test assessments.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Due to the necessity of maintaining strict confidentiality regarding the personal and identity-related information of the participants (children and adolescents), in accordance with biomedical ethics codes, and given that written informed consent was not obtained from parents or participants for the public disclosure of raw data in open-access databases, there is no plan to share the Individual Participant Data (IPD). However, the aggregated results and statistical analyses of this study will be published in the form of a thesis and scientific manuscripts.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Faezeh Farajpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rahimian Hospital, Azadi 30th St, Moallem Blvd, Alvand</address>
        <city>Alvand</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3431855595</zip>
        <telephone>+98 28 3222 9701</telephone>
        <email>Rahimian.hospital@qums.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nooshin Abbasi Abyaneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Educational Block 1, 5th Floor, Science and Research Branch, Islamic Azad University, Shohadaye Hesarak Blvd, Daneshgah Sq, End of North Sattari Highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1477893855</zip>
        <telephone>+98 21 2200 4355</telephone>
        <email>nooshin.abbasi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 12 and 18 years at the time of entry into the study.
Definitive diagnosis of type 1 diabetes mellitus by a pediatric endocrinologist based on standard diagnostic criteria.
At least 6 months of documented history of type 1 diabetes to ensure familiarity of the adolescent and family with disease management principles.
Receiving insulin therapy as the primary treatment regimen.
Regular follow-up at the diabetes clinic or pediatric endocrinology center during the study period.
Having at least one parent or primary caregiver (mother, father, or legal guardian) willing and able to participate in the family-centered empowerment program.
Absence of acute or chronic comorbid conditions that could affect diabetes self-management ability, participation in educational sessions, or outcome evaluations.
Ability of both the adolescent and parent/caregiver to communicate effectively and comprehend the educational content provided in the intervention sessions.
Ability to read, write, and comprehend educational materials and complete the study questionnaires.
No participation in similar structured diabetes education, self-management promotion programs, or family-centered empowerment interventions within the past 6 months.
Providing written informed consent by parents or legal guardians along with written informed assent from the adolescent prior to study enrollment.</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Occurrence of acute medical complications: Development of acute diabetes complications (such as severe diabetic ketoacidosis or hypoglycemia requiring emergency intervention) or any other acute underlying illness leading to prolonged hospitalization that prevents active participation in the study.
Non-adherence to the intervention protocol: Absence from more than one-third (or more than two sessions) of the educational intervention sessions or failure to perform the activities and follow-ups specified in the empowerment model.
Voluntary withdrawal: The desire of the parent or adolescent to withdraw from the study at any stage of the research process.
Major changes in the treatment regimen: Implementation of significant and unusual changes in the adolescent’s medication/treatment protocol outside of the routine clinic plan during the intervention period.
Migration or loss to follow-up: Change of residence, lack of response to follow-ups, or inability to establish communication for post-test evaluations.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Insulin-dependent diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in the intervention group along with one of their parents will participate in an educational program based on the Family-Centered Empowerment Model (FCEM). The program consists of six 90-minute educational sessions conducted bi-weekly over 3 months (in-person and in small groups) at the hospital diabetes clinic. The intervention follows four steps: 1) Enhancing perceived threat (knowledge about diabetes nature, complications, and consequences of poor control), 2) Improving self-efficacy through problem-solving and practical skills (hands-on blood glucose monitoring, insulin injection technique, dietary and physical activity management, and handling emergencies), 3) Increasing self-esteem through educational participation (reinforcing the adolescent’s role as an educational ambassador to share learning with family members and peer discussions), and 4) Formative and summative evaluation (assessing knowledge retention, addressing questions, and treatment adherence). An educational booklet will also be provided at the end of the intervention.</i_keyword>
      <i_keyword>Control group: Participants in the control group will only receive routine care and standard education provided at the hospital diabetes clinic (including periodic physician visits and standard advice from healthcare providers), with no structured empowerment program. To comply with research ethics, an educational summary booklet of the empowerment model will be provided to the control group participants and their families after completion of the study and post-test assessments.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Diabetes self-management score measured by the standardized Diabetes Self-Management Questionnaire (comprising 27 items across 4 domains: glucose monitoring, diet, physical activity, and healthcare contact, scored on a 5-point Likert scale with total score ranging from 27 to 135). Timepoint: At baseline (prior to intervention) and 3 months after completion of the intervention. Method of measurement: Self-reporting completion of the standardized Diabetes Self-Management Questionnaire by the adolescent.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-20</approval_date>
        <contact_name>Ethics Committee of Tehran Islamic Azad University of Medical Sciences</contact_name>
        <contact_address>Faculty of Nursing and Midwifery, Educational Block 1, Science and Research Branch, Islamic Azad University, Shohada-ye Hesarak Blvd, Daneshgah Sq, End of Shahid Sattari Expressway, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
